Topics:
Radiation Oncology • Rheumatology
Should TNF inhibitors be held in patients undergoing radiation therapy?
Is there a risk of increased radioresistance or secondary malignancy (or conversely, toxicity) for patients on TNF inhibitors such as infliximab or etanercept? If so, how long should they be held and is there an alternative therapy for rheumatoid arthritis that is well tolerated with RT?
Answer from: at Academic Institution
We do not hold TNF inhibitors when needed for patients undergoing radiation therapy.
Sign in or Register to read more